Thus, prolactin level, body mass index, alanine aminotransferase, HDL cholesterol, and HbA1cA are included in a new noninvasive model for the prediction of NAFLD presence (138). The gene discussed is PRL; the disease is metabolic dysfunction-associated steatotic liver disease.